Engrail Therapeutics Acquisitions
Engrail Therapeutics has acquired 1 company and its latest acquisition was NeuroCycle Therapeutics on Feb 2021
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
NeuroCycle Therapeutics
Feb 2021
Source »undisclosed
NeuroCycle is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of dravet syndrome.